219
Views
15
CrossRef citations to date
0
Altmetric
Technology Evaluation

High-throughput in vitro hemotoxicity testing and in vitro cross-platform comparative toxicity

Pages 295-307 | Published online: 11 Apr 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jianling Wang, Laszlo Urban & Dejan Bojanic. (2007) Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety. Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 641-665.
Read now

Articles from other publishers (14)

Laurie G. O'Rourke. 2022. Schalm's Veterinary Hematology. Schalm's Veterinary Hematology 100 107 .
Eva-Maria Dehne, Annika Winter & Uwe Marx. (2019) Microphysiological systems in the evaluation of hematotoxicities during drug development. Current Opinion in Toxicology 17, pages 18-22.
Crossref
Prathap Kumar Mahalingaiah, Tammy Palenski & Terry R. Van Vleet. (2018) An In Vitro Model of Hematotoxicity: Differentiation of Bone Marrow–Derived Stem/Progenitor Cells into Hematopoietic Lineages and Evaluation of Lineage‐Specific Hematotoxicity. Current Protocols in Toxicology 76:1.
Crossref
Sabine Sewing, Adrian B. Roth, Michael Winter, Andreas Dieckmann, Cristina Bertinetti-Lapatki, Yann Tessier, Claudia McGinnis, Sylwia Huber, Erich Koller, Corinne Ploix, John C. Reed, Thomas Singer & Andreas Rothfuss. (2017) Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia. PLOS ONE 12:11, pages e0187574.
Crossref
Dori Germolec, Robert Luebke, Andrew Rooney, Kelly Shipkowski, Rob Vandebriel & Henk van Loveren. (2017) Immunotoxicology: A brief history, current status and strategies for future immunotoxicity assessment. Current Opinion in Toxicology 5, pages 55-59.
Crossref
. (2017) Publisher's note. Current Opinion in Toxicology 3, pages 75-79.
Crossref
Ivan Rich & Andrew J. Olaharski. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology 172 181 .
Liang Guo, John HamreIIIIII, Myrtle Davis & Ralph E. Parchment. (2016) Human CD34+ progenitor hematopoiesis in liquid culture for in vitro assessment of drug-induced myelotoxicity. Toxicology in Vitro 31, pages 103-113.
Crossref
Holli Harper & Ivan N. Rich. 2015. Stem Cell Protocols. Stem Cell Protocols 33 48 .
Caroline Haglund, Rolf Larsson & Martin Höglund. 2013. High‐Throughput Screening Methods in Toxicity Testing. High‐Throughput Screening Methods in Toxicity Testing 421 429 .
Patrizia Crivori, Giulia Pennella, Miriam Magistrelli, Pietro Grossi & Anna Maria Giusti. (2011) Predicting Myelosuppression of Drugs from in Silico Models. Journal of Chemical Information and Modeling 51:2, pages 434-445.
Crossref
Andrew J. Olaharski, Hirdesh Uppal, Matthew Cooper, Stefan Platz, Tanja S. Zabka & Kyle L. Kolaja. (2009) In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates. Toxicology Letters 188:2, pages 98-103.
Crossref
Jo-Anna Reems, Karen M. Hall, Luladay H. Gebru, Greta Taber & Ivan N. Rich. (2008) Development of a novel assay to evaluate the functional potential of umbilical cord blood progenitors. Transfusion 48:4, pages 620-628.
Crossref
Jianling Wang, Laszlo Urban & Dejan Bojanic. (2007) Maximising use of in vitro ADMET tools to predict in vivo bioavailability and safety . Expert Opinion on Drug Metabolism & Toxicology 3:5, pages 641-665.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.